BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 26744291)

  • 1. Tumour-induced osteomalacia: a literature review and a case report.
    Dadoniene J; Miglinas M; Miltiniene D; Vajauskas D; Seinin D; Butenas P; Kacergius T
    World J Surg Oncol; 2016 Jan; 14(1):4. PubMed ID: 26744291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET/CT localisation of a scapular haemangiopericytoma with tumour-induced osteomalacia.
    Khadgawat R; Singh Y; Kansara S; Tandon N; Bal C; Seith A; Kotwal P
    Singapore Med J; 2009 Feb; 50(2):e55-7. PubMed ID: 19296011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report.
    Tartaglia F; Minisola S; Sgueglia M; Blasi S; Brunelli D; Degli Effetti E; Maturo A; Cola A; Custureri F; Campana FP
    G Chir; 2006; 27(1-2):9-13. PubMed ID: 16608626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral subtrochanteric fractures in tumour-induced osteomalacia caused by a nasal haemangiopericytoma.
    Burnand H; Samuels A; Hagan I; Sawant N; Mutimer J
    Hip Int; 2012; 22(2):227-9. PubMed ID: 22547377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
    Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
    BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-induced osteomalacia.
    Minisola S; Peacock M; Fukumoto S; Cipriani C; Pepe J; Tella SH; Collins MT
    Nat Rev Dis Primers; 2017 Jul; 3():17044. PubMed ID: 28703220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-induced osteomalacia - a mystery illness beyond aches, pains, and depression.
    Ni HJ; Clifton-Bligh R; Brzozowska MM
    Endocr Regul; 2021 Sep; 55(3):163-168. PubMed ID: 34523297
    [No Abstract]   [Full Text] [Related]  

  • 8. Challenging case of tumour-induced osteomalacia.
    Kumar P; Jadhav DV; Ravat SH; Jain N
    BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35589273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in the management of tumor-induced osteomalacia (TIO).
    Brandi ML; Clunie GPR; Houillier P; Jan de Beur SM; Minisola S; Oheim R; Seefried L
    Bone; 2021 Nov; 152():116064. PubMed ID: 34147708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic osteomalacia: two case reports with surprisingly different outcomes.
    Seijas R; Ares O; Sierra J; Pérez-Dominguez M
    Arch Orthop Trauma Surg; 2009 Apr; 129(4):533-9. PubMed ID: 19125258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia.
    Fukumoto S; Takeuchi Y; Nagano A; Fujita T
    Bone; 1999 Sep; 25(3):375-7. PubMed ID: 10495143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left maxillary sinus tumour-induced hypophosphataemic osteomalacia and combined with thyroid papillary carcinoma: a case report and literature review.
    Li B; Dong Y; Liu D; Yao Q; Guo S; Xin H; Wang H; Liu L; Zhang Y
    Intern Med J; 2020 Jun; 50(6):755-761. PubMed ID: 32537923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oncogenic osteomalacia in a 49-year-old female patient].
    Ludwig J; Mechtersheimer G; Haberkorn U; Nawroth P; Schilling T; Kasperk C
    Dtsch Med Wochenschr; 2005 Feb; 130(5):206-9. PubMed ID: 15678388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1.
    Hannan FM; Athanasou NA; Teh J; Gibbons CL; Shine B; Thakker RV
    Eur J Endocrinol; 2008 Feb; 158(2):265-71. PubMed ID: 18230836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic osteomalacia, a rare paraneoplastic syndrome due to phosphate wasting--a case report and review of the literature.
    Woznowski M; Quack I; Stegbauer J; Büchner N; Rump LC; Schieren G
    Clin Nephrol; 2008 Nov; 70(5):431-8. PubMed ID: 19000546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic osteomalacia from pterygopalatine fossa mass.
    Savage CR; Zimmer LA
    J Laryngol Otol; 2009 Sep; 123(9):1052-4. PubMed ID: 19250593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sinonasal hemangiopericytoma caused hypophosphatemic osteomalacia: A case report.
    Li J; Huang Y; Yang F; Zhang Q; Chen D; Wang Q
    Medicine (Baltimore); 2018 Dec; 97(52):e13849. PubMed ID: 30593185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor induced osteomalacia from a peripheral mesenchymal tumour of the foot.
    Strydom A; Greeff W; Ferrao PNF; Saragas NP
    Foot (Edinb); 2023 May; 55():101979. PubMed ID: 36871520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.
    Shimada T; Mizutani S; Muto T; Yoneya T; Hino R; Takeda S; Takeuchi Y; Fujita T; Fukumoto S; Yamashita T
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6500-5. PubMed ID: 11344269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia.
    Takeuchi Y; Suzuki H; Ogura S; Imai R; Yamazaki Y; Yamashita T; Miyamoto Y; Okazaki H; Nakamura K; Nakahara K; Fukumoto S; Fujita T
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3979-82. PubMed ID: 15292336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.